Fuan Pharmaceutical ( Group) Co., Ltd.
|
Tigecycline is a new broad-spectrum active intravenous antibiotic that is also active against resistant methicillin-resistant Staphylococcus aureus and is the first drug in glycylcycline.
The product has USDMF #27477 |
Send Inquiry
|
Wuhan RS Pharmaceuticals Co., Ltd.
|
Tigecycline
CAS NO.: 220620-09-7
|
Send Inquiry
|
Sailong Pharmaceutical Group Co.,Ltd
|
1. Adults and patients over 18 years old
Tigecycline is applicable to the infection caused by sensitive strains of specific bacteria in patients aged 18 and above, including complex intraperitoneal infection; Complex skin and skin soft tissue infections; Community acquired bacterial pneumonia.
2. Children over 8 years old
Tigecycline for infections without other drugs, after discussion by experienced infection doctors or clinicians, this product is suitable for the treatment of infections caused by sensitive strains of specific bacteria in children aged 8 years and over, including complex abdominal infection; Complex skin and skin soft tissue infection. |
Send Inquiry
|